@article{55979d24d64c4e32a90b8d96dc71f80c,
title = "ASLPrep: a platform for processing of arterial spin labeled MRI and quantification of regional brain perfusion",
abstract = "Arterial spin labeled (ASL) magnetic resonance imaging (MRI) is the primary method for noninvasively measuring regional brain perfusion in humans. We introduce ASLPrep, a suite of software pipelines that ensure the reproducible and generalizable processing of ASL MRI data.",
keywords = "Brain/diagnostic imaging, Cerebrovascular Circulation, Humans, Magnetic Resonance Imaging/methods, Perfusion, Spin Labels",
author = "{the ALLFTD consortium} and Azeez Adebimpe and Maxwell Bertolero and Sudipto Dolui and Matthew Cieslak and Kristin Murtha and Baller, {Erica B.} and Bradley Boeve and Adam Boxer and Butler, {Ellyn R.} and Phil Cook and Stan Colcombe and Sydney Covitz and Christos Davatzikos and Davila, {Diego G.} and Elliott, {Mark A.} and Flounders, {Matthew W.} and Franco, {Alexandre R.} and Gur, {Raquel E.} and Gur, {Ruben C.} and Basma Jaber and Corey McMillian and Liana Apostolova and Brian Appleby and Sami Barmada and Yvette Bordelon and Hugo Botha and Boxer, {Adam L.} and Andrea Bozoki and Danielle Brushaber and David Clark and Giovanni Coppola and Ryan Darby and Dennis Dickson and Kimiko Domoto-Reilly and Kelley Faber and Anne Fagan and Fields, {Julie A.} and Tatiana Foroud and Forsberg, {Leah K.} and Daniel Geschwind and Jill Goldman and Galasko, {Douglas R.} and Ralitza Gavrilova and Tania Gendron and Jonathon Graff-Radford and Neill Graff-Radford and Grant, {Ian M.} and Murray Grossman and Matthew Hall and Masdeu, {Joseph C.}",
note = "Funding Information: We acknowledge the support of the following grants: nos. RF1MH121867 (O.E., R.A.P., T.D.S., M.M.), R01MH120482 (T.D.S. and M.M.), R01EB022573 (C.D. and T.D.S.), F31MH126569 (D.Z.), R01MH123550 (T.D.S.), T32MH019112 (E.B.B. and R.E.G.), R01MH120811 (D.J.O.), R01MH112847 (T.D.S.), R01MH112070 (C.D.), RF1AG054409 (C.D.), U01AG052943 (C.M.), U19AG063911 (B.B. and H.R.), AG062422 (H.R.), AG045333 (H.R.), AG019724 (H.R.), P01AG066597 (C.M.), P41EB015893 (J.A.D.), R01MH111886 (D.J.O.), R01MH119219 (R.E.G. and R.C.G.), R01AG054519 (J.S.P.), K01AG061277 (J.S.P.), R01MH120174 (D.R.R.), R01MH119185 (D.R.R.), R03AG063213 (S.D.), R01NS111115 and P30AG072979 (J.A.D.), and the Swiss National Science Foundation - Ambizione 185872 (O.E.). Support was provided by the Dutch Heart Foundation (2020T049; H.J.M.M.M.), by the Eurostars-2 joint program (H.J.M.M.M.) with cofunding from the European Union Horizon 2020 research and innovation program (ASPIRE E!113701) provided by the Netherlands Enterprise Agency (RvO), the EU Joint Program for Neurodegenerative Disease Research provided by the Netherlands Organization for health Research and Development and Alzheimer Nederland (DEBBIE JPND2020-568-106; H.J.M.M.M.), and the AE foundation (T.D.S.). Additional support was provided by the Center for Biomedical Image Computing and Analytics (CBICA; A.A., M.C., T.D.S. and C.D.) the Penn-CHOP Lifespan Brain Institute (LiBI; T.D.S., R.C.G. and R.E.G.). Funding Information: We acknowledge the support of the following grants: nos. RF1MH121867 (O.E., R.A.P., T.D.S., M.M.), R01MH120482 (T.D.S. and M.M.), R01EB022573 (C.D. and T.D.S.), F31MH126569 (D.Z.), R01MH123550 (T.D.S.), T32MH019112 (E.B.B. and R.E.G.), R01MH120811 (D.J.O.), R01MH112847 (T.D.S.), R01MH112070 (C.D.), RF1AG054409 (C.D.), U01AG052943 (C.M.), U19AG063911 (B.B. and H.R.), AG062422 (H.R.), AG045333 (H.R.), AG019724 (H.R.), P01AG066597 (C.M.), P41EB015893 (J.A.D.), R01MH111886 (D.J.O.), R01MH119219 (R.E.G. and R.C.G.), R01AG054519 (J.S.P.), K01AG061277 (J.S.P.), R01MH120174 (D.R.R.), R01MH119185 (D.R.R.), R03AG063213 (S.D.), R01NS111115 and P30AG072979 (J.A.D.), and the Swiss National Science Foundation - Ambizione 185872 (O.E.). Support was provided by the Dutch Heart Foundation (2020T049; H.J.M.M.M.), by the Eurostars-2 joint program (H.J.M.M.M.) with cofunding from the European Union Horizon 2020 research and innovation program (ASPIRE E!113701) provided by the Netherlands Enterprise Agency (RvO), the EU Joint Program for Neurodegenerative Disease Research provided by the Netherlands Organization for health Research and Development and Alzheimer Nederland (DEBBIE JPND2020-568-106; H.J.M.M.M.), and the AE foundation (T.D.S.). Additional support was provided by the Center for Biomedical Image Computing and Analytics (CBICA; A.A., M.C., T.D.S. and C.D.) the Penn-CHOP Lifespan Brain Institute (LiBI; T.D.S., R.C.G. and R.E.G.). Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer Nature America, Inc.",
year = "2022",
month = jun,
doi = "10.1038/s41592-022-01458-7",
language = "English (US)",
volume = "19",
pages = "683--686",
journal = "Nature Methods",
issn = "1548-7091",
publisher = "Public Library of Science",
number = "6",
}